This compound is primarily utilized in the field of targeted protein degradation, particularly in the development of proteolysis-targeting chimeras (PROTACs). It serves as a key ligand that binds to E3 ubiquitin ligase, facilitating the ubiquitination and subsequent degradation of specific proteins of interest. This mechanism is highly valuable in research focused on understanding disease pathways, especially in cancers and neurodegenerative disorders, where the selective removal of pathogenic proteins can offer therapeutic benefits. Additionally, it is employed in chemical biology studies to explore protein function and regulation, aiding in the discovery of novel drug targets and therapeutic strategies. Its role in PROTAC technology underscores its significance in advancing precision medicine and targeted therapies.